Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817199-26-000024 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
33,024
Total Value
$319,539.79
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Jul 2, 2026 | Exercise/Conversion | 5,221 | $1.86 | $9,711.06 | 18,800 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jul 2, 2026 | Exercise/Conversion | 5,787 | $8.72 | $50,462.64 | 24,587 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jul 2, 2026 | Sale | 11,008 | $23.56 | $259,366.09 | 13,579 | Direct | โ | View Details | |
Chief Legal Officer | Employee Stock Option (right to buy) | Derivative | Jul 2, 2026 | Exercise/Conversion | 5,221 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer | Employee Stock Option (right to buy) | Derivative | Jul 2, 2026 | Exercise/Conversion | 5,787 | $0.00 | $0.00 | 128,611 | Direct | โ | View Details |